| Literature DB >> 35873341 |
Subham G Patel1, Ruturajsinh M Vala1, Paras J Patel1, Dipti B Upadhyay1, V Ramkumar2, Ramesh L Gardas2, Hitendra M Patel1.
Abstract
Herein, acetic acid mediated multicomponent synthesis of novel 2,4-dimethoxy-tetrahydropyrimido[4,5-b]quinolin-6(7H)-one (2,4-dimethoxy-THPQs) was reported. Single-crystal XRD analysis of four newly developed crystals of 2,4-dimethoxy-THPQs and their DFT study were also reported. The structure of all molecules was optimized using DFT B3LYP/6-31G(d) level and compared with the corresponding single-crystal XRD data. As a result, the theoretical and experimental geometrical parameters (bond lengths and bond angles) were found to be in good agreement. Frontier molecular orbital (FMO) and molecule electrostatic potential (MEP) analyses were used to investigate the physicochemical properties and relative reactivity of 2,4-dimethoxy-THPQs. The formation of strong C-H⋯O and N-H⋯O interaction was investigated by Hirshfeld analysis. Furthermore, electronic charge density concentration in 2,4-dimethoxy-THPQs was analysed by the Mulliken atomic charges which helps to predict the ability of 2,4-dimethoxy-THPQs to bind in the receptor. The molecular docking of the crystal structure of 2,4-dimethoxy-THPQs in the main protease (Mpro) of SARS-CoV-2 suggested that all four 2,4-dimethoxy-THPQs efficiently docked in Mpro. Furthermore, 2,4-dimethoxy-THPQs with a 3-chloro substitution in the phenyl ring have the highest binding affinity because of the additional formation of halogen bonds and highest dipole moment. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35873341 PMCID: PMC9240959 DOI: 10.1039/d2ra02694e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Anti corona viral agents.
Crystal data and structure refinement of 4(a–d)
| Crystal data | 4a | 4b | 4c | 4d |
|---|---|---|---|---|
| CCDC no. |
|
|
|
|
| Empirical formula | C21H22N3O3Cl | C21H23N3O3 | C22H25N3O4 | C21H22N3O3Cl |
| Formula weight | 399.86 | 365.42 | 395.45 | 399.86 |
| Temperature (K) | 296(2) | 296(2) | 296(2) | 296(2) |
| Crystal system | Triclinic | Monoclinic | Monoclinic | Monoclinic |
| Space group |
|
|
|
|
|
| 6.1119(17), 12.856(3), 13.503(2) | 11.3367(6), 13.5799(7), 13.0546(6) | 12.5837(13), 13.0752(17), 13.0356(16) | 12.2403(6), 13.3075(7), 12.8408(7) |
|
| 74.018(10), 83.479(15), 76.619(15) | 90, 108.872(2), 90 | 90, 110.844(5), 90 | 90, 109.168(2), 90 |
| Volume (Å3) | 990.8(4) | 1901.73(17) | 2004.4(4) | 1975.65(18) |
|
| 2 | 4 | 4 | 4 |
|
| 1.340 | 1.276 | 1.310 | 1.344 |
| (μ mm−1) | 0.220 | 0.087 | 0.091 | 0.221 |
|
| 420.0 | 776.0 | 840.0 | 840.0 |
| Crystal size (mm3) | 0.28 × 0.22 × 0.16 | 0.28 × 0.22 × 0.16 | 0.25 × 0.22 × 0.1 | 0.25 × 0.12 × 0.1 |
| Radiation | Mo Kα ( | Mo Kα ( | Mo Kα ( | Mo Kα ( |
| 2 | 3.142 to 49.994 | 4.146 to 50 | 1.93 to 25.0 | 3.99 to 50 |
| Absorption correction | Multi-scan | Multi-scan | Multi-scan | Multi-scan |
|
| 0.941, 0.966 | 0.976, 0.986 | 0.978, 0.991 | 0.947, 0.978 |
| Reflections collected | 4723 | 15821 | 12334 | 13789 |
| Independent reflections | 2395 [ | 3353 [ | 3528 [ | 3472 [ |
| Refinement method | Full-matrix least-squares on | |||
| Refinement program | SHELXL-2014/7 (Sheldrick, 2014) | |||
| Data/restraints/parameters | 2395/0/261 | 3353/0/253 | 3528/0/268 | 3472/0/257 |
| Goodness-of-fit on | 1.083 | 1.556 | 1.029 | 1.015 |
| Final |
|
|
|
|
| Final |
|
|
|
|
| Largest diff. peak, hole (e Å−3) | 0.20, −0.27 | 0.18, −0.18 | 0.201, −0.186 | 0.39, −0.38 |
Scheme 1Three-component synthesis of 4a from 4-chlorobenzaldehyde, dimedone and 6-amino-2,4-dimethoxypyrimidine.
Optimisation of solvent and catalyst for the synthesis of 4aa
| Entries | Catalyst | Solvent | Temperature | Time (h) | Conversion relative to aldehyde |
|---|---|---|---|---|---|
| 1 | — | Water | rt | 12 | NR |
| 2 | — | Ethanol | rt | 12 | NR |
| 3 | — | Ethanol | Reflux | 12 |
|
| 4 | PTSA (20 mol%) | Ethanol | Reflux | 6 | 100% |
| 5 | PTSA (20 mol%) | Acetonitrile | Reflux | 8.5 | 100% |
| 6 | PTSA (20 mol%) | Acetic acid | rt | 5 | 100% |
| 7 | PTSA (20 mol%) | Acetic acid | Reflux | 1.5 | 100% |
| 8 | — | Acetic acid | rt | 5 | 100% |
|
|
|
|
|
|
|
Reaction condition: 1 mmol p-chlorobenzaldehyde 1a, 1 mmol dimedone 2 and 1 mmol 6-amino-2,4-dimethoxypyrimidine.
3 mL solvent.
Observed from TLC analysis.
Substrate scope of the synthesis of 2,4-dimethoxy-THPQs 4(a–d)a
|
| ||||
|---|---|---|---|---|
| Entries | R | Product | Time (min) | % Yield |
| 1 | 4-Cl | 4a | 90 | 73 |
| 2 | 4-H | 4b | 90 | 71 |
| 3 | 3-OMe | 4c | 90 | 72 |
| 4 | 3-Cl | 4d | 90 | 68 |
Reaction condition: 1 mmol aldehyde 1(a–d), 1 mmol dimedone 2 and 1 mmol 6-amino-2,4-dimethoxypyrimidine 3.
Isolated yield.
Fig. 6Correlation graph of theoretical and experimental parameters of 4a.
Fig. 7Correlation graph of theoretical and experimental parameters of 4(b–d) using B3LYP/6-31G(d) basis sets in the gaseous phase.
Fig. 8Molecular orbital diagrams and calculated HOMO–LUMO energy levels for 4(a–d).
Calculated chemical quantum parameters of dimethoxy-THPQs 4(a–d)a
| Parameter | 4a | 4b | 4c | 4d |
|---|---|---|---|---|
|
| −5.868 | −5.717 | −5.581 | −5.858 |
|
| −1.313 | −1.173 | −1.136 | −1.306 |
|
| 4.555 | 4.544 | 4.445 | 4.552 |
| IP (eV) | 5.868 | 5.717 | 5.586 | 5.858 |
| EA (eV) | 1.313 | 1.173 | 1.136 | 1.306 |
|
| 2.277 | 2.272 | 2.222 | 2.276 |
|
| 0.220 | 0.220 | 0.225 | 0.220 |
|
| 3.590 | 3.445 | 3.359 | 3.582 |
|
| −3.590 | −3.445 | −3.359 | −3.582 |
|
| 2.830 | 2.612 | 2.538 | 2.818 |
| Dipole moment ( | 4.219 | 2.511 | 3.916 | 4.668 |
B3LYP/6-31G(d) was used in a gaseous state.
Fig. 9The molecular electrostatic potential surface of the molecule 4(a–d).
Fig. 10HS mapped over dnorm and 2D fingerprint plots showing relative contributions (%) to the HS area for the several close intermolecular contacts in 2,4-dimethoxy-THPQ 4a.
Fig. 11HS mapped over dnorm and 2D fingerprint plots showing relative contributions (%) to the HS area for the several close intermolecular contacts in 2,4-dimethoxy-THPQ 4b.
Fig. 12HS mapped over dnorm and 2D fingerprint plots showing relative contributions (%) to the HS area for the several close intermolecular contacts in 2,4-dimethoxy-THPQ 4c.
Fig. 13HS mapped over dnorm and 2D fingerprint plots showing relative contributions (%) to the HS area for the several close intermolecular contacts in 2,4-dimethoxy-THPQ 4d.
Mulliken atomic charges of the molecule 4(a–d)
| Molecule 4a | Molecule 4b | Molecule 4c | Molecule 4d | ||||
|---|---|---|---|---|---|---|---|
| Atom | Charges | Atom | Charges | Atom | Charges | Atom | Charges |
| C1 | 0.330 | C1 | 0.329 | C1 | −0.351 | C1 | 0.330 |
| C2 | −0.357 | C2 | −0.357 | C2 | 0.079 | C2 | −0.357 |
| C3 | 0.080 | C3 | 0.081 | C3 | −0.351 | C3 | 0.080 |
| C4 | −0.354 | C4 | −0.353 | C4 | 0.404 | C4 | −0.354 |
| C5 | 0.407 | C5 | 0.405 | C5 | 0.029 | C5 | 0.407 |
| C6 | 0.022 | C6 | 0.022 | C6 | −0.307 | C6 | 0.021 |
| C7 | −0.308 | C7 | −0.308 | C7 | 0.049 | C7 | −0.308 |
| C8 | 0.044 | C8 | 0.049 | C8 | 0.534 | C8 | 0.046 |
| C9 | 0.536 | C9 | 0.534 | C9 | 0.678 | C9 | 0.536 |
| C10 | 0.677 | C10 | 0.677 | C10 | 0.502 | C10 | 0.677 |
| C11 | 0.495 | C11 | 0.495 | C11 | 0.325 | C11 | 0.495 |
| C12 | 0.198 | C12 | −0.449 | C12 | −0.450 | C12 | −0.455 |
| C13 | −0.167 | C13 | −0.456 | C13 | −0.451 | C13 | −0.450 |
| C14 | −0.135 | C14 | 0.198 | C14 | 0.195 | C14 | 0.198 |
| C15 | −0.066 | C15 | −0.159 | C15 | −0.241 | C15 | −0.167 |
| C16 | −0.133 | C16 | −0.134 | C16 | 0.375 | C16 | −0.071 |
| C17 | −0.187 | C17 | −0.130 | C17 | −0.198 | C17 | −0.131 |
| C18 | −0.207 | C18 | −0.133 | C18 | −0.143 | C18 | −0.132 |
| C19 | −0.204 | C19 | −0.191 | C19 | −0.171 | C19 | −0.184 |
| C20 | −0.450 | C20 | −0.206 | C20 | −0.207 | C20 | −0.207 |
| C21 | −0.455 | C21 | −0.203 | C21 | −0.202 | C21 | −0.204 |
| N1 | −0.753 | N1 | −0.754 | C22 | −0.211 | N1 | −0.755 |
| N2 | −0.582 | N2 | −0.584 | N1 | −0.757 | N2 | −0.582 |
| N3 | −0.568 | N3 | −0.562 | N2 | −0.596 | N3 | −0.551 |
| O1 | −0.503 | O1 | −0.502 | N3 | −0.554 | O1 | −0.500 |
| O2 | −0.488 | O2 | −0.487 | O1 | −0.457 | O2 | −0.487 |
| O3 | −0.455 | O3 | −0.458 | O2 | −0.488 | O3 | −0.457 |
| Cl1 | −0.038 | H1N | 0.337 | O3 | −0.511 | Cl1 | −0.035 |
| H1N | 0.339 | H2A | 0.149 | O4 | −0.500 | H1N | 0.338 |
| H2A | 0.150 | H2B | 0.164 | H1N | 0.332 | H2A | 0.150 |
| H2B | 0.165 | H4A | 0.155 | H1A | 0.140 | H2B | 0.165 |
| H4A | 0.156 | H4B | 0.162 | H1B | 0.169 | H4A | 0.156 |
| H4B | 0.163 | H7 | 0.171 | H3A | 0.158 | H4B | 0.164 |
| H7 | 0.174 | H12A | 0.140 | H3B | 0.159 | H7 | 0.175 |
| H13 | 0.160 | H12B | 0.149 | H6 | 0.172 | H12A | 0.139 |
| H14 | 0.152 | H12C | 0.141 | H13A | 0.140 | H12B | 0.151 |
| H16 | 0.149 | H13A | 0.138 | H13B | 0.141 | H12C | 0.164 |
| H17 | 0.136 | H13B | 0.149 | H13C | 0.150 | H13A | 0.142 |
| H18A | 0.168 | H13C | 0.167 | H15 | 0.131 | H13B | 0.140 |
| H18B | 0.170 | H15 | 0.148 | H17 | 0.125 | H13C | 0.151 |
| H18C | 0.166 | H16 | 0.126 | H18 | 0.125 | H15 | 0.172 |
| H19A | 0.162 | H17 | 0.123 | H19 | 0.144 | H17 | 0.149 |
| H19B | 0.166 | H18 | 0.123 | H20A | 0.169 | H18 | 0.134 |
| H19C | 0.163 | H19 | 0.125 | H20B | 0.165 | H19 | 0.132 |
| H20A | 0.150 | H20A | 0.167 | H20C | 0.173 | H20A | 0.168 |
| H20B | 0.142 | H20B | 0.169 | H21A | 0.159 | H20B | 0.172 |
| H20C | 0.150 | H20C | 0.164 | H21B | 0.164 | H20C | 0.166 |
| H21A | 0.165 | H21A | 0.165 | H21C | 0.162 | H21A | 0.166 |
| H21B | 0.139 | H21B | 0.161 | H22A | 0.150 | H21B | 0.162 |
| H21C | 0.150 | H21C | 0.162 | H22B | 0.149 | H21C | 0.162 |
| H22C | 0.165 | ||||||
Fig. 14Protein–ligand interaction diagram of 4a and 4b with Mpro of SARS-CoV-2.
Fig. 15Protein–ligand interaction diagram of 4c and 4d with Mpro of SARS-CoV-2.